Tree Level Unitarity Bounds for the Minimal B-L Model

We have derived the unitarity bounds in the high energy limit for the minimal B-L extension of the Standard Model by analysing the full class of Higgs and would-be Goldstone boson two-to-two scatterings at tree level. Moreover, we have investigated how these limits could vary at some lower critical value of the energy.Comment: 20 pages, 4 figures, 2 tables; 1d figure modified, typos corrected, bibliography augmented; published in PRD after minor adjustmen

The Z' boson of the minimal B-L model at future Linear Colliders in e+e- --> mu+mu-

We study the capabilities of future electron-positron Linear Colliders, with centre-of-mass energy at the TeV scale, in accessing the parameter space of a $Z'$ boson within the minimal $B-L$ model. We carry out a detailed comparison between the discovery regions mapped over a two-dimensional configuration space ($Z'$ mass and coupling) at the Large Hadron Collider and possible future Linear Colliders for the case of di-muon production. As known in the literature for other $Z'$ models, we confirm that leptonic machines, as compared to the CERN hadronic accelerator, display an additional potential in discovering a $Z'$ boson as well as in allowing one to study its properties at a level of precision well beyond that of any of the existing colliders.Comment: 5 pages, proceeding of LC09 (Perugia), published by the Italian Physical Society in the Nuovo Cimento C (Colloquia

A singlet-triplet extension for the Higgs search at LEP and LHC

We describe a simple extension of the standard model, containing a scalar singlet and a triplet fermion. The model can explain the possible enhancement in the decay $H \rightarrow \gamma \gamma$ at the LHC together with the excess found in the Higgs boson search at LEP2. The structure of the model is motivated by a recent argument, that was used to explain the number of fermion generations. For the sake of completenes we also considered the contributions from higher multiplets.Comment: 12 pages, 2 figure

Scaling function in AdS/CFT from the O(6) sigma model

Asymptotic behavior of the anomalous dimensions of Wilson operators with high spin and twist is governed in planar N=4 SYM theory by the scaling function which coincides at strong coupling with the energy density of a two-dimensional bosonic O(6) sigma model. We calculate this function by combining the two-loop correction to the energy density for the O(n) model with two-loop correction to the mass gap determined by the all-loop Bethe ansatz in N=4 SYM theory. The result is in agreement with the prediction coming from the thermodynamical limit of the quantum string Bethe ansatz equations, but disagrees with the two-loop stringy corrections to the folded spinning string solution.Comment: 25 pages, 2 figure

[2017 Honorable Mention] The American Dream (Some Restrictions May Apply): Racial Boundaries to Class Mobility in American Immigration Narratives

This paper analyzes three works of fiction to see the role that race plays in immigrants\u27 ability to achieve social mobility.https://digitalcommons.csumb.edu/esa_submissions/1021/thumbnail.jp

Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience.

The objectives of this study were to evaluate the effectiveness of nab-paclitaxel plus gemcitabine (NAB-P/GEM) regimen in an unselected population of patients with advanced inoperable or metastatic pancreatic cancer (PC), and to identify the prognostic factors influencing overall survival (OS). EXPERIMENTAL DESIGN: Patients with age < 85 years, ECOG-performance status (PS) < 3, and adequate renal, hepatic and hematologic function were eligible. NAB-P (125 mg/m2) and GEM (1000 mg/m2) day 1,8,15 every 4 weeks were employed for 3-6 cycles or until highest response. RESULTS: Overall, 147 cycles (median 4, range 1-11 cycles) were administered on thirty-seven consecutive patients (median 66 years old, range 40-82) treated. The median overall progression-free survival and OS were 6.2 and 9.2 months, respectively. The G 3-4 dose-limiting toxicity were neutropenia (20.7%), severe anemia (17.2%), and cardiovascular toxicity (10.3%). PS, number of cycles, baseline CA 19-9 and LDH serum levels, were found to be significantly related to OS. The multivariate analysis showed that both number of cycles (HR = 9.14, 95% CI 1.84-45.50, p = 0.001) and PS (HR = 13.18, 95% CI 2.73-63.71, p = 0.001) were independently associated with OS. CONCLUSION: NAB-P/GEM regimen should be used in all patients with advanced or metastatic PC, with the exception of those with serious contraindications to chemotherapy, such as severe renal or hepatic impairment or major cardiovascular diseases